Supplementary Figure 1 from Nonclinical Evaluation of the Serum Pharmacodynamic Biomarkers HGF and Shed MET following Dosing with the Anti-MET Monovalent Monoclonal Antibody Onartuzumab
التفاصيل البيبلوغرافية
العنوان:
Supplementary Figure 1 from Nonclinical Evaluation of the Serum Pharmacodynamic Biomarkers HGF and Shed MET following Dosing with the Anti-MET Monovalent Monoclonal Antibody Onartuzumab
American Association for Cancer Research (AACR), 2023.
سنة النشر:
2023
الوصف:
PDF file - 21K, Supplemental Figure 1. Human sMET (A) and HGF (B) levels in human plasma samples from a panel of 20 renal cell carcinoma patients and 15 normal donors were measured using the MET ECLA (A) and HGF ELISA (B), respectively.
